➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Merck
Colorcon
Harvard Business School
Dow

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

Apotex Inc Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for APOTEX INC, and what generic and branded alternatives to APOTEX INC drugs are available?

APOTEX INC has one hundred and thirty-eight approved drugs.

There are twenty-one tentative approvals on APOTEX INC drugs.

Drugs and US Patents for Apotex Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 091265-001 Oct 24, 2011 AB RX No No   Start Trial   Start Trial
Apotex Inc RISEDRONATE SODIUM risedronate sodium TABLET;ORAL 090877-002 Jun 10, 2014 AB RX No No   Start Trial   Start Trial
Apotex Inc DICLOFENAC SODIUM diclofenac sodium SOLUTION/DROPS;OPHTHALMIC 077600-001 Nov 13, 2008 DISCN No No   Start Trial   Start Trial
Apotex Inc ALPRAZOLAM alprazolam TABLET;ORAL 077741-004 Jan 19, 2007 AB RX No No   Start Trial   Start Trial
Apotex Inc GABAPENTIN gabapentin TABLET;ORAL 077894-002 Oct 10, 2006 AB RX No No   Start Trial   Start Trial
Apotex Inc ARMODAFINIL armodafinil TABLET;ORAL 201514-002 Mar 25, 2019 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Johnson and Johnson
Moodys
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.